Report Detail

Other Global Exocrine Pancreatic Insufficiency Market Size, Status and Forecast 2019-2025

  • RnM3466993
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Exocrine Pancreatic Insufficiency Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Nutritional management
      • 1.4.3 Pancreatic enzyme replacement therapy (PERT)
      • 1.4.4 Life style modifications approach
    • 1.5 Market by Application
      • 1.5.1 Global Exocrine Pancreatic Insufficiency Market Share by Application (2014-2025)
      • 1.5.2 Nutritional management
      • 1.5.3 Pancreatic enzyme replacement therapy (PERT)
      • 1.5.4 Life style modifications approach
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Exocrine Pancreatic Insufficiency Market Size
    • 2.2 Exocrine Pancreatic Insufficiency Growth Trends by Regions
      • 2.2.1 Exocrine Pancreatic Insufficiency Market Size by Regions (2014-2025)
      • 2.2.2 Exocrine Pancreatic Insufficiency Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Exocrine Pancreatic Insufficiency Market Size by Manufacturers
      • 3.1.1 Global Exocrine Pancreatic Insufficiency Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Exocrine Pancreatic Insufficiency Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Exocrine Pancreatic Insufficiency Market Concentration Ratio (CR5 and HHI)
    • 3.2 Exocrine Pancreatic Insufficiency Key Players Head office and Area Served
    • 3.3 Key Players Exocrine Pancreatic Insufficiency Product/Solution/Service
    • 3.4 Date of Enter into Exocrine Pancreatic Insufficiency Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Exocrine Pancreatic Insufficiency Market Size by Type (2014-2019)
    • 4.2 Global Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Exocrine Pancreatic Insufficiency Market Size (2014-2019)
    • 5.2 Exocrine Pancreatic Insufficiency Key Players in United States
    • 5.3 United States Exocrine Pancreatic Insufficiency Market Size by Type
    • 5.4 United States Exocrine Pancreatic Insufficiency Market Size by Application

    6 Europe

    • 6.1 Europe Exocrine Pancreatic Insufficiency Market Size (2014-2019)
    • 6.2 Exocrine Pancreatic Insufficiency Key Players in Europe
    • 6.3 Europe Exocrine Pancreatic Insufficiency Market Size by Type
    • 6.4 Europe Exocrine Pancreatic Insufficiency Market Size by Application

    7 China

    • 7.1 China Exocrine Pancreatic Insufficiency Market Size (2014-2019)
    • 7.2 Exocrine Pancreatic Insufficiency Key Players in China
    • 7.3 China Exocrine Pancreatic Insufficiency Market Size by Type
    • 7.4 China Exocrine Pancreatic Insufficiency Market Size by Application

    8 Japan

    • 8.1 Japan Exocrine Pancreatic Insufficiency Market Size (2014-2019)
    • 8.2 Exocrine Pancreatic Insufficiency Key Players in Japan
    • 8.3 Japan Exocrine Pancreatic Insufficiency Market Size by Type
    • 8.4 Japan Exocrine Pancreatic Insufficiency Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Exocrine Pancreatic Insufficiency Market Size (2014-2019)
    • 9.2 Exocrine Pancreatic Insufficiency Key Players in Southeast Asia
    • 9.3 Southeast Asia Exocrine Pancreatic Insufficiency Market Size by Type
    • 9.4 Southeast Asia Exocrine Pancreatic Insufficiency Market Size by Application

    10 India

    • 10.1 India Exocrine Pancreatic Insufficiency Market Size (2014-2019)
    • 10.2 Exocrine Pancreatic Insufficiency Key Players in India
    • 10.3 India Exocrine Pancreatic Insufficiency Market Size by Type
    • 10.4 India Exocrine Pancreatic Insufficiency Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Exocrine Pancreatic Insufficiency Market Size (2014-2019)
    • 11.2 Exocrine Pancreatic Insufficiency Key Players in Central & South America
    • 11.3 Central & South America Exocrine Pancreatic Insufficiency Market Size by Type
    • 11.4 Central & South America Exocrine Pancreatic Insufficiency Market Size by Application

    12 International Players Profiles

    • 12.1 Axcan Pharma
      • 12.1.1 Axcan Pharma Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Exocrine Pancreatic Insufficiency Introduction
      • 12.1.4 Axcan Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
      • 12.1.5 Axcan Pharma Recent Development
    • 12.2 Aptalis Pharma
      • 12.2.1 Aptalis Pharma Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Exocrine Pancreatic Insufficiency Introduction
      • 12.2.4 Aptalis Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
      • 12.2.5 Aptalis Pharma Recent Development
    • 12.3 Eli Lilly
      • 12.3.1 Eli Lilly Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Exocrine Pancreatic Insufficiency Introduction
      • 12.3.4 Eli Lilly Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
      • 12.3.5 Eli Lilly Recent Development
    • 12.4 Cilian
      • 12.4.1 Cilian Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Exocrine Pancreatic Insufficiency Introduction
      • 12.4.4 Cilian Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
      • 12.4.5 Cilian Recent Development
    • 12.5 Nordmark Arzneimittel
      • 12.5.1 Nordmark Arzneimittel Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Exocrine Pancreatic Insufficiency Introduction
      • 12.5.4 Nordmark Arzneimittel Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
      • 12.5.5 Nordmark Arzneimittel Recent Development
    • 12.6 Laboratoires Mayoly Spindler
      • 12.6.1 Laboratoires Mayoly Spindler Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Exocrine Pancreatic Insufficiency Introduction
      • 12.6.4 Laboratoires Mayoly Spindler Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
      • 12.6.5 Laboratoires Mayoly Spindler Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas.
      EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic cells, which generates the digestive enzymes. EPI disturbs the normal growth, life expectancy and immune response. Diarrhoea, Steatorrhea, fatigue and weight loss are the key symptoms of EPI.
      In 2018, the global Exocrine Pancreatic Insufficiency market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Exocrine Pancreatic Insufficiency status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Exocrine Pancreatic Insufficiency development in United States, Europe and China.

      The key players covered in this study
      Axcan Pharma
      Aptalis Pharma
      Eli Lilly
      Cilian
      Nordmark Arzneimittel
      Laboratoires Mayoly Spindler
      ...

      Market segment by Type, the product can be split into
      Nutritional management
      Pancreatic enzyme replacement therapy (PERT)
      Life style modifications approach

      Market segment by Application, split into
      Nutritional management
      Pancreatic enzyme replacement therapy (PERT)
      Life style modifications approach

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Exocrine Pancreatic Insufficiency status, future forecast, growth opportunity, key market and key players.
      To present the Exocrine Pancreatic Insufficiency development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Exocrine Pancreatic Insufficiency are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Exocrine Pancreatic Insufficiency. Industry analysis & Market Report on Exocrine Pancreatic Insufficiency is a syndicated market report, published as Global Exocrine Pancreatic Insufficiency Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Exocrine Pancreatic Insufficiency market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,081.12
      4,621.69
      6,162.25
      3,537.80
      5,306.70
      7,075.60
      423,126.60
      634,689.90
      846,253.20
      278,422.17
      417,633.26
      556,844.34
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report